Log in
OTCMKTS:CTHZ

Cancer Treatment Stock Forecast, Price & News

$0.15
0.00 (0.00 %)
(As of 12/1/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.15
Now: $0.15
$0.15
50-Day Range
$0.04
MA: $0.06
$0.15
52-Week Range
$0.04
Now: $0.15
$0.20
VolumeN/A
Average Volume2,183 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-3.59
Cancer Treatment Holdings, Inc., through its subsidiaries, engages in providing IT-enabled services; the exploitation of an invention related to the on-site production of chlorine gas and related compounds; and providing radiation therapy, diagnostic imaging, and other medical related services. The company, through a 50% interest in a joint venture, offers IT-enabled services, including medical transcriptions, billing and collecting, bookkeeping, and claims processing services. The company enables users to manufacture chlorine on-site and when needed through its device. It has a 51% interest in a radiation therapy center located in Logan, West Virginia. In addition, through its wholly owned subsidiary, CTI Management Corp., the company's president provides management services. The company is based in Carson City, Nevada.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.17 out of 5 stars


Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CTHZ
CUSIPN/A
CIKN/A
WebN/A
Phone212-221-1340
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
$0.15
0.00 (0.00 %)
(As of 12/1/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CTHZ News and Ratings via Email

Sign-up to receive the latest news and ratings for CTHZ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cancer Treatment (OTCMKTS:CTHZ) Frequently Asked Questions

What stocks does MarketBeat like better than Cancer Treatment?

Wall Street analysts have given Cancer Treatment a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cancer Treatment wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cancer Treatment?

Cancer Treatment saw a decline in short interest in October. As of October 30th, there was short interest totaling 400 shares, a decline of 20.0% from the October 15th total of 500 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 4.0 days.
View Cancer Treatment's Short Interest
.

Who are some of Cancer Treatment's key competitors?

Who are Cancer Treatment's key executives?

Cancer Treatment's management team includes the following people:
  • Dr. Ullrich Klamm Ph.D., Chairman, Chief Exec. Officer, Chief Financial Officer and Pres (Age 81, Pay $156.6k)
  • Mr. Mark V. Stephenson, Sec. (Age 60)

What is Cancer Treatment's stock symbol?

Cancer Treatment trades on the OTCMKTS under the ticker symbol "CTHZ."

How do I buy shares of Cancer Treatment?

Shares of CTHZ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cancer Treatment's stock price today?

One share of CTHZ stock can currently be purchased for approximately $0.15.

How can I contact Cancer Treatment?

Cancer Treatment's mailing address is 540 JOAN DRIVE, FAIRFIELD CT, 06430. The company can be reached via phone at 212-221-1340.

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.